Firms

Longwood Fund

Longwood Fund

longwoodfund.com

Longwood Fund is a Boston-based life sciences venture capital firm founded in 2010 that builds biotechnology companies and invests in therapeutics from early company formation through clinical development. Its team combines venture investing, scientific diligence, company creation and operating support, with dedicated early-stage and growth-stage investment activity. Its neuroscience portfolio includes Newleos Therapeutics, Engrail Therapeutics and Progentos Therapeutics. The current public directory lists 16 staff and venture partners, supported by 20 living members of a Strategic Advisory Board. Christoph Westphal is co-founder and general partner; Rich Aldrich is co-founder and partner. In May 2023, Longwood announced USD180 million committed to its sixth fund and related vehicles; its July 2020 fifth-fund announcement reported approximately USD170 million including two related incubator funds. These are aggregate commitments, with individual legal fund sizes not separately disclosed in those announcements.

Founded
—
Type
Venture capital

Funds2

  • Longwood Fund VI—

    Sixth fund, announced at closing with USD180 million committed to the fund and related vehicles. Aggregate commitment figure; individual legal fund size is not separately disclosed in the announcement. Supports Longwood-founded biotechnology companies and early financing rounds.

  • Longwood Fund V—

    Fifth fund, announced at closing with approximately USD170 million in aggregate commitments to Longwood Fund V LP and two related incubator funds. Individual fund-only amount is not separately disclosed. Supports company creation and first institutional financing of therapeutics and medical platforms.

Team

Operations and support

Al SandrockAl SandrockStrategic Advisory Board Member
Aleks Radovic-MorenoAleks Radovic-MorenoPartner
Anne KlibanskiAnne KlibanskiStrategic Advisory Board Member
Aparaajita BalajiAparaajita BalajiAssociate
Arielle JacksonArielle JacksonHead of Corporate Communications and Industry Engagement
Barry GreeneBarry GreeneStrategic Advisory Board Member
Christina StephensChristina StephensExecutive Assistant
Christoph WestphalChristoph WestphalCo-Founder and General Partner
Christophe WeberChristophe WeberStrategic Advisory Board Member
Deborah DunsireDeborah DunsireStrategic Advisory Board Member
Fiona MarshallFiona MarshallStrategic Advisory Board Member
Jay BradnerJay BradnerStrategic Advisory Board Member
John MaraganoreJohn MaraganoreStrategic Advisory Board Member
John McCabeJohn McCabeOperating Partner
Josh LubovJosh LubovChief Financial Officer
Julie MullenJulie MullenOperations Manager
K. Dane WittrupK. Dane WittrupStrategic Advisory Board Member
Kai WucherpfennigKai WucherpfennigStrategic Advisory Board Member
Kevin LewisKevin LewisController
Laurie GlimcherLaurie GlimcherStrategic Advisory Board Member
Lea HachigianLea HachigianVenture Partner
Lotte Bjerre KnudsenLotte Bjerre KnudsenStrategic Advisory Board Member
Lou LangeLou LangeStrategic Advisory Board Member
Melissa MagnerMelissa MagnerExecutive Assistant
Paul SchimmelPaul SchimmelStrategic Advisory Board Member
Phil SharpPhil SharpStrategic Advisory Board Member
Rich AldrichRich AldrichCo-Founder and Partner
Rob HadfieldRob HadfieldGeneral Counsel and Operating Partner
Roger TungRoger TungVenture Partner
Sally KornbluthSally KornbluthStrategic Advisory Board Member
Sean O’ConnorSean O’ConnorPrincipal
Stefan OelrichStefan OelrichStrategic Advisory Board Member
Stephen ElledgeStephen ElledgeStrategic Advisory Board Member
Victor DzauVictor DzauStrategic Advisory Board Member
Vikas GoyalVikas GoyalPartner
William HaitWilliam HaitStrategic Advisory Board Member

Co-investing

Alexandria Venture Investments
ARCH Venture Partners
Forbion
Agent Capital
Alta Partners

Investments

$93M2025-02-13Newleos TherapeuticsLife Sciences at Goldman Sachs Alternatives, DCVC Bio, Novo Holdings, Longwood Fund, Arkin Bio Capital
$65M2024-05-20Progentos TherapeuticsForbion, Alta Partners, Mission BioCapital, Longwood Fund, Dolby Family Ventures
$167M2024-03-19Engrail TherapeuticsNorwest Venture Partners, F-Prime Capital, Forbion, Longwood Fund, RiverVest Venture Partners, Red Tree Venture Capital, Ysios Capital, Eight Roads, Pivotal Life Sciences, Foresite Capital
$213M2023-12-12Tome BiosciencesARCH Venture Partners, Alexandria Venture Investments, GV, Polaris Partners, Longwood Fund, FUJIFILM Corporation
$76M2021-05-18Interius BioTherapeuticsBain Capital, Cormorant Asset Management, Longwood Fund, Agent Capital, Knollwood Investment Advisory, BrightEdge, Osage University Partners
$50MUnknown dateImmuneIDARCH Venture Partners, Alexandria Venture Investments, Xfund, In-Q-Tel, Longwood Fund, Tekla Capital Management